Can anaesthetic and analgesic techniques affect cancer recurrence or metastasis?

British Journal of Anaesthesia

Volumn 109, Issue SUPPL1, 2012, Pages

  Heaney, A ^a   Buggy, D J ^a,b  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

anaesthesia; metastases; recurrence, cancer; regional, cancer

Indexed keywords

17 METHYLNALTREXONE; ALPHA 2 ADRENERGIC RECEPTOR; ANGIOSTATIN; BUPIVACAINE; CYTOKINE; FENTANYL; FIBROBLAST GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INHALATION ANESTHETIC AGENT; ISOFLURANE; KETAMINE; LIDOCAINE; LOCAL ANESTHETIC AGENT; MATRIX METALLOPROTEINASE; MU OPIATE RECEPTOR; NITROGEN; NITROUS OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYGEN; PROPOFOL; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; REMIFENTANIL; ROPIVACAINE; SEVOFLURANE; THIOPENTAL; TRANSFORMING GROWTH FACTOR BETA; UNINDEXED DRUG; VASCULOTROPIN;

ANESTHESIOLOGICAL PROCEDURE; ANGIOGENESIS; ARTICLE; BLOOD TRANSFUSION; CANCER CELL; CANCER GROWTH; CANCER INCIDENCE; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURGERY; CARCINOGENESIS; CELL SURVIVAL; CELLULAR IMMUNITY; CHRONIC PAIN; CYTOLOGY; EPIDURAL ANESTHESIA; GENERAL ANESTHESIA; HUMAN; HUMORAL IMMUNITY; HYPOTHERMIA; IMMUNE DEFICIENCY; INFLAMMATION; LOW DRUG DOSE; MENTAL STRESS; METASTASIS; MINIMAL RESIDUAL DISEASE; MORBIDITY; NATURAL KILLER T CELL; NONHUMAN; POSTOPERATIVE PAIN; PRIMARY TUMOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGIONAL ANESTHESIA; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; SPINAL ANESTHESIA; THORAX EPIDURAL ANESTHESIA; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

EID: 84871181966     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aes421     Document Type: Article

References (99)

1. American Cancer Society. Cancer Facts and Figures 2012. Available from http://www.cancer.org/research/cancerfactsfigures/ cancer-facts-figures-2012. Atlanta: American Cancer Society, 2012 (accessed 30 August 2012)
2. Cancer Research UK. CancerStats: cancer Stats for the UK. Available from http://www.cancerresearchuk.org/cancer-info/cancerstats/incidence (accessed 30 August 2012)
3. Kurosawa S. Anesthesia in patients with cancer disorders. Curr Opin Anaesthesiol 2012; 25: 376-84
4. Talmadge JE, Fidler IJ. AACR centennial series: The biology of cancer metastasis: Historical perspective. Cancer Res 2010; 70: 5649-69
5. Snyder GL, Greenberg S. Effect of anaesthetic technique and other perioperative factors on cancer recurrence. Br J Anaesth 2010; 105: 106-15
6. Kavanagh T, Buggy DJ. Can anaesthetic technique effect postoperative outcome? Curr Opin Anaesthesiol 2012; 25: 185-98
7. Fidler IJ. The pathogenesis of cancer metastasis: The seed and soil hypothesis revisited. Nat Rev 2003; 3: 453-8 (Pubitemid 37328849)
8. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70 (Pubitemid 30046295)
9. Langley RR, Fidler IJ. The seed and soil hypothesis revisited - the role of tumor-stroma interactions in metastasis to different organs. Int J Cancer 2011; 128: 2527-35
10. O'Riain SC, Buggy DJ, Kerin MJ, Watson RW, Moriarty DC. Inhibition of the stress response to breast cancer surgery by regional anesthesia and analgesia does not affect vascular endothelial growth factor and prostaglandin E2. Anesth Analg 2005; 100: 244-9 (Pubitemid 40013636)
11. Qian B, Deng Y, Im JH, et al. A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth. PLoS One 2009; 4: E6562
12. Conrick-Martin I, Kell MR, Buggy DJ. Meta-analysis of the effect of central neuraxial regional anesthesia compared with general anesthesia on postoperative natural killer T lymphocyte function. J Clin Anesth 2012; 24: 3-7
13. Ben-Eliyahu S, Page GG, Yirmiya R, Shakhar G. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer 1999; 80: 880-8 (Pubitemid 29108864)
14. Gottschalk A, Sharma S, Ford J, Durieux ME, Tiouririne M. Review article: The role of the perioperative period in recurrence after cancer surgery. Anesth Analg 2010; 110: 1636-43
15. Raman D, Baugher PJ, Thu YM, Richmond A. Role of chemokines in tumor growth. Cancer Lett 2007; 256: 137-65 (Pubitemid 47418345)
16. Motohashi S, Nakayama T. Natural killer T cell-mediated immunotherapy for malignant diseases. Front Biosci (Schol Ed) 2009; 1: 108-16
17. Goldfarb Y, Sorski L, Benish M, Levi B, Melamed R, Ben-Eliyahu S. Improving postoperative immune status and resistance to cancer metastasis: A combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses. Ann Surg 2011; 253: 798-810
18. Neeman E, Ben-Eliyahu S. Surgery and stress promote cancer metastasis: New outlooks on perioperative mediating mechanisms and immune involvement. Brain Behav Immun 2012. Advance access published on 4 April 2012. PMID: 22504092
19. Peach G, Kim C, Zacharakis E, Purkayastha S, Ziprin P. Prognostic significance of circulating tumour cells following surgical resection of colorectal cancers: A systematic review. Br J Cancer 2010; 102: 1327-34
20. Buggy DJ, Smith G. Epidural anaesthesia and analgesia: Better outcome after major surgery? Growing evidence suggests so. BMJ 1999; 319: 530-1 (Pubitemid 29403629)
21. Goldfarb Y, Ben-Eliyahu S. Surgery as a risk factor for breast cancer recurrence and metastasis: Mediating mechanisms and clinical prophylactic approaches. Breast Dis 2006; 26: 99-114 (Pubitemid 46655482)
22. Wada H, Seki S, Takahashi T, et al. Combined spinal and general anesthesia attenuates liver metastasis by preserving TH1/TH2 cytokine balance. Anesthesiology 2007; 106: 499-506 (Pubitemid 46662215)
23. Lloyd JM, McIver CM, Stephenson SA, Hewett PJ, Rieger N, Hardingham JE. Identification of early-stage colorectal cancer patients at risk of relapse post-resection by immunobead reverse transcription-PCR analysis of peritoneal lavage fluid for malignant cells. Clin Cancer Res 2006; 12: 417-23 (Pubitemid 43166130)
24. Benish M, Bartal I, Goldfarb Y, et al. Perioperative use of betablockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann Surg Oncol 2008; 15: 2042-52
25. Looney M, Doran P, Buggy DJ. Effect of anesthetic technique on serum vascular endothelial growth factor C and transforming growth factor beta in women undergoing anesthesia and surgery for breast cancer. Anesthesiology 2010; 113: 1118-25
26. Deegan CA, Murray D, Doran P, et al. Anesthetic technique and the cytokine and matrix metalloproteinase response to primary breast cancer surgery. Reg Anesth Pain Med 2010; 35: 490-5
27. Lee JW, Shahzad MM, Lin YG, et al. Surgical stress promotes tumor growth in ovarian carcinoma. Clin Cancer Res 2009; 15: 2695-702
28. Thaker PH, Han LY, Kamat AA, et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 2006; 12: 939-44 (Pubitemid 44175146)
29. Wang HL, Ning T, Li M, et al. Effect of endostatin on preventing postoperative progression of distant metastasis in a murine lung cancer model. Tumori 2011; 97: 787-93
30. Melamed R, Bar-Yosef S, Shakhar G, Shakhar K, Ben-Eliyahu S. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: Mediating mechanisms and prophylactic measures. Anesth Analg 2003; 97: 1331-9 (Pubitemid 37310130)
31. Yuki K, Astrof NS, Bracken C, Soriano SG, Shimaoka M. Sevoflurane binds and allosterically blocks integrin lymphocyte functionassociated antigen-1. Anesthesiology 2010; 113: 600-9
32. Loop T, Dovi-Akue D, Frick M, et al. Volatile anesthetics induce caspase-dependent, mitochondria-mediated apoptosis in human T lymphocytes in vitro. Anesthesiology 2005; 102: 1147-57 (Pubitemid 40745833)
33. Wei H, Liang G, Yang H, et al. The common inhalational anesthetic isoflurane induces apoptosis via activation of inositol 1,4,5-trisphosphate receptors. Anesthesiology 2008; 108: 251-60 (Pubitemid 351156735)
34. Tavare AN, Perry NJ, Benzonana LL, Takata M, Ma D. Cancer recurrence after surgery: Direct and indirect effects of anesthetic agents. Int J Cancer 2012; 130: 1237-50
35. Kawaraguchi Y, Horikawa YT, Murphy AN, et al. Volatile anesthetics protect cancer cells against tumor necrosis factorrelated apoptosis-inducing ligand-induced apoptosis via caveolins. Anesthesiology 2011; 115: 499-508
36. Huitink JM, Heimerikxs M, Nieuwland M, et al. Volatile anesthetics modulate gene expression in breast and brain tumor cells. Anesth Analg 2010; 111: 1411-5
37. Muller-Edenborn B, Roth-Z'graggen B, Bartnicka K, et al. Volatile anesthetics reduce invasion of colorectal cancer cells through down-regulation of matrix metalloproteinase-9. Anesthesiology 2012; 117: 293-301
38. Fleischmann E, Marschalek C, Schlemitz K, et al. Nitrous oxide may not increase the risk of cancer recurrence after colorectal surgery: A follow-up of a randomized controlled trial. BMC Anesthesiol 2009; 9: 1
39. Inada T, Kubo K, Shingu K. Possible link between cyclooxygenaseinhibiting and antitumor properties of propofol. J Anesth 2011; 25: 569-75
40. Ohta N, Ohashi Y, Fujino Y. Ketamine inhibits maturation of bone marrow-derived dendritic cells and priming of the Th1-type immune response. Anesth Analg 2009; 109: 793-800
41. Forget P, Collet V, Lavand'homme P, De Kock M. Does analgesia and condition influence immunity after surgery? Effects of fentanyl, ketamine and clonidine on natural killer activity at different ages. Eur J Anaesthesiol 2010; 27: 233-40
42. Beilin B, Rusabrov Y, Shapira Y, et al. Low-dose ketamine affects immune responses in humans during the early postoperative period. Br J Anaesth 2007; 99: 522-7 (Pubitemid 47412495)
43. Sakaguchi M, Kuroda Y, Hirose M. The antiproliferative effect of lidocaine on human tongue cancer cells with inhibition of the activity of epidermal growth factor receptor. Anesth Analg 2006; 102: 1103-7
44. Lucchinetti E, Awad AE, Rahman M, et al. Antiproliferative effects of local anesthetics on mesenchymal stem cells: Potential implications for tumor spreading and wound healing. Anesthesiology 2012; 116: 841-56
45. Lirk P, Berger R, Hollmann MW, Fiegl H. Lidocaine time- and dosedependently demethylates deoxyribonucleic acid in breast cancer cell lines in vitro. Br J Anaesth 2012; 109: 200-7
46. Werdehausen R, Braun S, Fazeli S, et al. Lipophilicity but not stereospecificity is a major determinant of local anaestheticinduced cytotoxicity in human T-lymphoma cells. Eur J Anaesthesiol 2012; 29: 35-41
47. Luthy IA, Bruzzone A, Pinero CP, et al. Adrenoceptors: Non conventional target for breast cancer? Curr Med Chem 2009; 16: 1850-62
48. Afsharimani B, Cabot P, Parat MO. Morphine and tumor growth and metastasis. Cancer Metastasis Rev 2011; 30: 225-38
49. Colvin LA, Fallon MT, Buggy DJ. Cancer biology, analgesics, and anaesthetics: Is there a link? Br J Anaesth 2012; 109: 140-3
50. Kraus J. Regulation of mu-opioid receptors by cytokines. Front Biosci (Schol Ed) 2009; 1: 164-70
51. Gach K, Wyrebska A, Fichna J, Janecka A. The role of morphine in regulation of cancer cell growth. Naunyn Schmiedebergs Arch Pharmacol 2011; 384: 221-30
52. Afsharimani B, Cabot PJ, Parat MO. Morphine use in cancer surgery. Front Pharmacol 2011; 2: 46
53. Franchi S, Moretti S, Castelli M, et al. Mu opioid receptor activation modulates Toll like receptor 4 in murine macrophages. Brain Behav Immun 2012; 26: 480-8
54. Ecimovic P, Murray D, Doran P, McDonald J, Lambert DG, Buggy DJ. Direct effect of morphine on breast cancer cell function in vitro: Role of the NET1 gene. Br J Anaesth 2011; 107: 916-23
55. Lin X, Wang YJ, Li Q, et al. Chronic high-dose morphine treatment promotes SH-SY5Y cell apoptosis via c-Jun N-terminal kinase-mediated activation of mitochondria-dependent pathway. FEBS J 2009; 276: 2022-36
56. Mathew B, Lennon FE, Siegler J, et al. The novel role of the mu opioid receptor in lung cancer progression: A laboratory investigation. Anesth Analg 2011; 112: 558-67
57. Lennon FE, Mirzapoiazova T, Mambetsariev B, Salgia R, Moss J, Singleton PA. Overexpression of the mu-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis. Anesthesiology 2012; 116: 857-67
58. Singleton PA, Lingen MW, Fekete MJ, Garcia JG, Moss J. Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: Role of receptor transactivation. Microvasc Res 2006; 72: 3-11 (Pubitemid 44118390)
59. Gach K, Szemraj J, Fichna J, et al. The influence of opioids on urokinase plasminogen activator on protein and mRNA level in MCF-7 breast cancer cell line. Chem Biol Drug Des 2009; 74: 390-396
60. Nylund G, Pettersson A, Bengtsson C, et al. Functional expression of mu-opioid receptors in the human colon cancer cell line, HT-29, and their localization in human colon. Dig Dis Sci 2008; 53: 461-466 (Pubitemid 351170037)
61. Harimaya Y, Koizumi K, Andoh T, et al. Potential ability of morphine to inhibit the adhesion, invasion and metastasis of metastatic colon 26-L5 carcinoma cells. Cancer Lett 2002; 187: 121-127 (Pubitemid 35279340)
62. Hsiao PN, Chang MC, Cheng WF, et al. Morphine induces apoptosis of human endothelial cells through nitric oxide and reactive oxygen species pathways. Toxicology 2009; 256: 83-91
63. Hatsukari I, Hitosugi N, Ohno R, et al. Induction of apoptosis by morphine in human tumor cell lines in vitro. Anticancer Res 2007; 27: 857-64 (Pubitemid 46586991)
64. Singleton PA, Garcia JG, Moss J. Synergistic effects of methylnaltrexone with 5-fluorouracil and bevacizumab on inhibition of vascular endothelial growth factor-induced angiogenesis. Mol Cancer Ther 2008; 7: 1669-79
65. Farooqui M, Li Y, Rogers T, et al. COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. Br J Cancer 2007; 97: 1523-31 (Pubitemid 350175846)
66. Koodie L, Ramakrishnan S, Roy S. Morphine suppresses tumor angiogenesis through a HIF-1alpha/p38MAPK pathway. Am J Pathol 2010; 177: 984-97
67. Sarkar DK, Murugan S, Zhang C, Boyadjieva N. Regulation of cancer progression by beta-endorphin neuron. Cancer Res 2012; 72: 836-40
68. Bortsov AV, Millikan RC, Belfer I, Boortz-Marx RL, Arora H, McLean SA. mu-Opioid receptor gene A118G polymorphism predicts survival in patients with breast cancer. Anesthesiology 2012; 116: 896-902
69. Page GG, Blakely WP, Ben-Eliyahu S. Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats. Pain 2001; 90: 191-9 (Pubitemid 32146573)
70. Wang D, Dubois RN. Eicosanoids and cancer. Nat Rev Cancer 2010; 10: 181-93
71. Holt D, Ma X, Kundu N, Fulton A. Prostaglandin E(2) (PGE (2)) suppresses natural killer cell function primarily through the PGE(2) receptor EP4. Cancer Immunol Immunother 2011; 60: 1577-86
72. Harris RE. Cyclooxygenase-2 (COX-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung. Inflammopharmacology 2009; 17: 55-67
73. Ruder EH, Laiyemo AO, Graubard BI, Hollenbeck AR, Schatzkin A, Cross AJ. Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort. Am J Gastroenterol 2011; 106: 1340-50
74. Zhao YS, Zhu S, Li XW, et al. Association between NSAIDs use and breast cancer risk: A systematic review and meta-analysis. Breast Cancer Res Treat 2009; 117: 141-50
75. Khan M, Fraser A. Cox-2 inhibitors and the risk of cardiovascular thrombotic events. Ir Med J 2012; 105: 119-21
76. Sessler DI. Does regional analgesia reduce the risk of cancer recurrence? A hypothesis. Eur J Cancer Prev 2008; 17: 269-72 (Pubitemid 351549668)
77. Bar-Yosef S, Melamed R, Page GG, Shakhar G, Shakhar K, Ben-Eliyahu S. Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats. Anesthesiology 2001; 94: 1066-73 (Pubitemid 32506136)
78. Deegan CA, Murray D, Doran P, Ecimovic P, Moriarty DC, Buggy DJ. Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro. Br J Anaesth 2009; 103: 685-90
79. Myles PS, Peyton P, Silbert B, et al. Perioperative epidural analgesia for major abdominal surgery for cancer and recurrence-free survival: Randomised trial. BMJ 2011; 342: D1491
80. Weber RS, Jabbour N, Martin RC II. Anemia and transfusions in patients undergoing surgery for cancer. Ann Surg Oncol 2008; 15: 34-45
81. Ng T, Ryder BA, Chern H, et al. Leukocyte-depleted blood transfusion is associated with decreased survival in resected early-stage lung cancer. J Thorac Cardiovasc Surg 2012; 143: 815-9
82. Churchhouse AM, Mathews TJ, McBride OM, Dunning J. Does blood transfusion increase the chance of recurrence in patients undergoing surgery for lung cancer? Interact Cardiovasc Thorac Surg 2012; 14: 85-90
83. Bjorneklett HG, Lindemalm C, Rosenblad A, et al. A randomised controlled trial of support group intervention after breast cancer treatment: Results on anxiety and depression. Acta Oncol 2012; 51: 198-207
84. Barron TI, Connolly RM, Sharp L, Bennett K, Visvanathan K. Beta blockers and breast cancer mortality: A population- based study. J Clin Oncol 2011; 29: 2635-44
85. Moslemi-Kebria M, El-Nashar SA, Aletti GD, Cliby WA. Intraoperative hypothermia during cytoreductive surgery for ovarian cancer and perioperative morbidity. Obstet Gynecol 2012; 119: 590-6
86. Exadaktylos AK, Buggy DJ, Moriarty DC, Mascha E, Sessler DI. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology 2006; 105: 660-4 (Pubitemid 44477309)
87. Biki B, Mascha E, Moriarty DC, Fitzpatrick JM, Sessler DI, Buggy DJ. Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: A retrospective analysis. Anesthesiology 2008; 109: 180-7
88. Wuethrich PY, Hsu Schmitz SF, Kessler TM, et al. Potential influence of the anesthetic technique used during open radical prostatectomy on prostate cancer-related outcome: A retrospective study. Anesthesiology 2010; 113: 570-6
89. Ismail H, Ho KM, Narayan K, Kondalsamy-Chennakesavan S. Effect of neuraxial anaesthesia on tumour progression in cervical cancer patients treated with brachytherapy: A retrospective cohort study. Br J Anaesth 2010; 105: 145-9
90. Gottschalk A, Ford JG, Regelin CC, et al. Association between epidural analgesia and cancer recurrence after colorectal cancer surgery. Anesthesiology 2010; 113: 27-34
91. Gupta A, Bjornsson A, Fredriksson M, Hallbook O, Eintrei C. Reduction in mortality after epidural anaesthesia and analgesia in patients undergoing rectal but not colonic cancer surgery: A retrospective analysis of data from 655 patients in central Sweden. Br J Anaesth 2011; 107: 164-70
92. Lin L, Liu C, Tan H, Ouyang H, Zhang Y, Zeng W. Anaesthetic technique may affect prognosis for ovarian serous adenocarcinoma: A retrospective analysis. Br J Anaesth 2011; 106: 814-22
93. de Oliveira GS Jr, Ahmad S, Schink JC, Singh DK, Fitzgerald PC, McCarthy RJ. Intraoperative neuraxial anesthesia but not postoperative neuraxial analgesia is associated with increased relapse-free survival in ovarian cancer patients after primary cytoreductive surgery. Reg Anesth Pain Med 2011; 36: 271-7
94. Lai R, Peng Z, Chen D, et al. The effects of anesthetic technique on cancer recurrence in percutaneous radiofrequency ablation of small hepatocellular carcinoma. Anesth Analg 2012; 114: 290-6
95. Day A, Smith R, Jourdan I, Fawcett W, Scott M, Rockall T. Retrospective analysis of the effect of postoperative analgesia on survival in patients after laparoscopic resection of colorectal cancer. Br J Anaesth 2012; 109: 185-90
96. Gottschalk A, Brodner G, Van Aken HK, Ellger B, Althaus S, Schulze HJ. Can regional anaesthesia for lymph-node dissection improve the prognosis in malignant melanoma? Br J Anaesth 2012; 109: 253-9
97. Christopherson R, James KE, Tableman M, Marshall P, Johnson FE. Long term survival after colon cancer surgery: A variation associated with choice of anaesthesia. Anesth Analg 2008; 107: 325-32
98. Tsui BC, Rashiq S, Schopflocher D, et al. Epidural anesthesia and cancer recurrence rates after radical prostatectomy. Can J Anaesth 2010; 57: 107-12
99. Cummings KC III, Xu F, Cummings LC, Cooper GS. A comparison of epidural analgesia and traditional pain management effects on survival and cancer recurrence after colectomy: A populationbased study. Anesthesiology 2012; 116: 797-806